RecruitingNCT02677064

Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia

Observational Study to Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia, Myelodysplastic Syndrome and Myelproliferative Neoplasms


Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

1,365 participants

Start Date

Feb 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

The investigators are doing this research study to assess the percentage of patients receiving stem cell transplantation for the type of blood cancer you have. They want to know how many patients get a transplant and why some patients do get a transplant while others do not. Also they want to explore why some patients elect not to undergo stem cell transplantation, when it is recommended by their physicians.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is identifying and understanding the obstacles — financial, logistical, social, or medical — that prevent patients who need an allogeneic stem cell transplant (a life-saving procedure using stem cells from a donor to treat blood cancers) from completing or even starting the transplant process, so that these barriers can be addressed and more patients can receive this treatment. **You may be eligible if...** - You have been referred for an allogeneic stem cell transplant (using cells donated by another person) to treat a blood cancer such as leukemia, lymphoma, or myeloma, or a related blood disorder - You have not yet undergone the transplant - You are willing to participate in interviews, surveys, or questionnaires about your experience navigating the transplant process - You are 18 years of age or older **You may NOT be eligible if...** - You have already completed your stem cell transplant - You are receiving a transplant using your own stem cells (autologous transplant), not a donor's cells - You are unwilling to participate in data collection, interviews, or follow-up surveys - You are under 18 years of age Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERassessments

All laboratory assessments performed on this study represent standard of care at our institution. HLA allele typing is performed by the center's HLA laboratory according to standard typing procedures.


Locations(3)

Hartford Healthcare Cancer Institute @ Hartford Hospital

Hartford, Connecticut, United States

Memorial Sloan Kettering Cancer Center

New York, New York, United States

Lehigh Valley Health Network

Allentown, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02677064


Related Trials